Furthermore, DPP4 plays a role in SARS-CoV-2 infection as a co-receptor, and sDPP4 levels are upregulated in obesity and T2DM, possibly complicating disease outcomes, if these patients acquire COVID-19. Here, DPP4 is linked to obesity disorder.